The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
This has further strengthened its manufacturing presence in the United States of America
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Subscribe To Our Newsletter & Stay Updated
